Portfolio > Case Study
Imvax
A clinical-stage biotech company with a unique immunotherapy approach that results in an innate and adaptive immune response.
Our portfolio
View all →
We invest wherever opportunity lives
Our portfolio proudly extends beyond verticals and asset classes
